PharmaCyte Biotech, Inc.
NASDAQ:PMCB
1.6 (USD) • At close December 24, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | PharmaCyte Biotech, Inc. |
Symbool | PMCB |
Munteenheid | USD |
Prijs | 1.6 |
Beurswaarde | 11,149,008 |
Dividendpercentage | 0% |
52-weken bereik | 1.39 - 2.58 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Mr. Joshua N. Silverman |
Website | https://pharmacyte.com |
An error occurred while fetching data.
Over PharmaCyte Biotech, Inc.
PharmaCyte Biotech, Inc., a biotechnology company, focuses on developing and commercializing cellular therapies for cancer, diabetes, and malignant ascites in the United States. Its cellular therapies are developed based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology used as a platform to treat various types of cancer, including advanced
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)